Fixed dose rate infusion of gemcitabine and UFT combination chemotherapy in patients with advanced biliary cancer

被引：0
|
作者：
Lee, S. [1 ,2 ,3 ,4 ,5 ,6 ,7 ,8 ]
Ryoo, H. [1 ,2 ,3 ,4 ,5 ,6 ,7 ,8 ]
Bae, S. [1 ,2 ,3 ,4 ,5 ,6 ,7 ,8 ]
Song, H. [1 ,2 ,3 ,4 ,5 ,6 ,7 ,8 ]
Kim, M. [1 ,2 ,3 ,4 ,5 ,6 ,7 ,8 ]
Lee, K. [1 ,2 ,3 ,4 ,5 ,6 ,7 ,8 ]
Lee, W. [1 ,2 ,3 ,4 ,5 ,6 ,7 ,8 ]
Park, K. [1 ,2 ,3 ,4 ,5 ,6 ,7 ,8 ]
Kim, J. [1 ,2 ,3 ,4 ,5 ,6 ,7 ,8 ]
Baek, J. [1 ,2 ,3 ,4 ,5 ,6 ,7 ,8 ]
机构：
[1] Daegu Gyeongbuk Oncol Group, Taegu, South Korea
[2] Daegu Cathol Univ Med Ctr, Taegu, South Korea
[3] Keimyung Univ Hosp, Taegu, South Korea
[4] Yeungnam Univ Hosp, Taegu, South Korea
[5] Daegu Fatima Hosp, Taegu, South Korea
[6] Dongguk Univ Hosp, Gyeungju, South Korea
[7] Kyungpook Natl Univ, Taegu, South Korea
[8] Ulsan Univ Hosp, Ulsan, South Korea
来源：
JOURNAL OF CLINICAL ONCOLOGY | 2009年 / 27卷 / 15期
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
e15581
引用
收藏
页数：2
相关论文
共 50 条
  • [41] Gemcitabine plus oxaliplatin combination in patients with advanced biliary tract cancer
    Vattemi, E.
    Lusso, M.
    Pedersini, R.
    Baier, S.
    Cretella, E.
    Petric, M.
    Stocker, J.
    Graiff, C.
    [J]. ANNALS OF ONCOLOGY, 2007, 18 : VII111 - VII111
  • [42] Fixed dose-rate gemcitabine (GEM) infusion in advanced pancreatic (PDAC) and biliary tree (BTC) carcinoma: A phase II study
    Gelibter, A
    Di Cosimo, S
    Ruggeri, EM
    Carlini, P
    Bria, E
    Malaguti, P
    Pellicciotta, M
    Terzoli, E
    Cognetti, F
    Milella, M
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2004, 22 (14) : 358S - 358S
  • [43] Fixed dose-rate gemcitabine infusion as first-line treatment for advanced-stage carcinoma of the pancreas and biliary tree
    Gelibter, A
    Malaguti, P
    Di Cosimo, S
    Bria, E
    Ruggeri, EM
    Carlini, P
    Carboni, F
    Ettorre, GM
    Pellicciotta, M
    Giannarelli, D
    Terzoli, E
    Cognetti, F
    Milella, M
    [J]. CANCER, 2005, 104 (06) : 1237 - 1245
  • [44] Fixed-dose rate infusion and standard rate infusion of gemcitabine in patients with advanced non-small-cell lung cancer: a meta-analysis of six trials
    Qiu, Man-Tang
    Ding, Xiang-Xiang
    Hu, Jing-Wen
    Tian, Hong-Ya
    Yin, Rong
    Xu, Lin
    [J]. CANCER CHEMOTHERAPY AND PHARMACOLOGY, 2012, 70 (06) : 861 - 873
  • [45] Gemcitabine and oxaliplatin combination chemotherapy in advanced biliary tract cancers
    Verderame, F.
    Russo, A.
    Di Leo, R.
    Badalamenti, G.
    Santangelo, D.
    Cicero, G.
    Valerio, M. R.
    Gulotta, G.
    Tomasello, G.
    Gebbia, N.
    Fulfaro, F.
    [J]. ANNALS OF ONCOLOGY, 2006, 17 : VII68 - VII72
  • [46] Fixed-dose rate infusion and standard rate infusion of gemcitabine in patients with advanced non-small-cell lung cancer: a meta-analysis of six trials
    Man-Tang Qiu
    Xiang-Xiang Ding
    Jing-Wen Hu
    Hong-Ya Tian
    Rong Yin
    Lin Xu
    [J]. Cancer Chemotherapy and Pharmacology, 2012, 70 : 861 - 873
  • [47] Prolonged fixed dose rate infusion of gemcitabine with autologous haemopoietic support in advanced pancreatic adenocarcinoma
    C Bengala
    V Guarneri
    E Giovannetti
    M Lencioni
    E Fontana
    V Mey
    A Fontana
    U Boggi
    M Del Chiaro
    R Danesi
    S Ricci
    F Mosca
    M Del Tacca
    P F Conte
    [J]. British Journal of Cancer, 2005, 93 : 35 - 40
  • [48] Prolonged fixed dose rate infusion of gemcitabine with autologous haemopoietic support in advanced pancreatic adenocarcinoma
    Bengala, C
    Guarneri, V
    Giovannetti, E
    Lencioni, M
    Fontana, E
    Mey, V
    Fontana, A
    Boggi, U
    Del Chiaro, M
    Danesi, R
    Ricci, S
    Mosca, F
    Del Tacca, M
    Conte, PF
    [J]. BRITISH JOURNAL OF CANCER, 2005, 93 (01) : 35 - 40
  • [49] Fixed dose rate infusion of gemcitabine with oral doxifluridine and leucovorin for advanced unresectable pancreatic cancer: A phase II study
    Kim, Hawk
    Park, Jae-Hoo
    Shin, Su Jin
    Kim, Mee-Ja
    Bang, Sung-Jo
    Park, Neung Hwa
    Nah, Yang Won
    Nam, Chang Woo
    Joo, Kwang Ro
    Min, Young Joo
    [J]. CHEMOTHERAPY, 2008, 54 (01) : 54 - 62
  • [50] Phase I/II study of gemcitabine as a fixed dose rate infusion and S-1 combination therapy (FGS) in gemcitabine-refractory pancreatic cancer patients
    Morizane, Chigusa
    Okusaka, Takuji
    Ueno, Hideki
    Kondo, Shunsuke
    Ikeda, Masafumi
    Furuse, Junji
    Shinichi, Ohkawa
    Nakachi, Kohei
    Mitsunaga, Shuichi
    Kojima, Yasushi
    Suzuki, Eiichiro
    Ueno, Makoto
    Yamaguchi, Tomohiro
    [J]. CANCER CHEMOTHERAPY AND PHARMACOLOGY, 2012, 69 (04) : 957 - 964
12345